Stefan Janssens
Overview
Explore the profile of Stefan Janssens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
217
Citations
8205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minten L, McCutcheon K, Vanhaverbeke M, Wouters L, Bezy S, Lesizza P, et al.
JACC Cardiovasc Interv
. 2024 Oct;
18(2):201-212.
PMID: 39474985
Background: The evaluation of myocardial ischemia in patients with aortic valve stenosis (AS) with concomitant coronary artery disease (CAD) and possible microvascular dysfunction (MVD) is challenging because fractional flow reserve...
2.
Meekers E, Martens P, Dauw J, Gruwez H, Dhont S, Nijst P, et al.
Eur J Heart Fail
. 2024 Aug;
26(10):2129-2139.
PMID: 39140288
Aims: Early evaluation of the natriuretic response is recommended to guide diuretic therapy in acute decompensated heart failure (ADHF). However, its implementation in daily practice is hampered by implementation barriers...
3.
Gulizia M, Turazza F, Ameri P, Alings M, Collins R, De Luca L, et al.
JACC Adv
. 2024 Aug;
3(7):100991.
PMID: 39130025
Background: Atrial fibrillation (AF) is a frequent cardiovascular (CV) comorbidity in cancer. Objectives: The purpose of this study was to examine clinical characteristics and contemporary management of patients with AF...
4.
Melgarejo J, van Eijgen J, Wei D, Maestre G, Al-Aswad L, Liao C, et al.
Front Cardiovasc Med
. 2024 Jun;
11:1432035.
PMID: 38903972
[This corrects the article DOI: 10.3389/fcvm.2022.1024044.].
5.
Van Wilder A, Bruyneel L, Cox B, Claessens F, Ridder D, Janssens S, et al.
Med Care
. 2024 May;
62(7):489-499.
PMID: 38775668
Background: Excessive interhospital variation threatens healthcare quality. Data on variation in patient outcomes across the whole cardiovascular spectrum are lacking. We aimed to examine interhospital variability for 28 cardiovascular All...
6.
Yu Y, Siwy J, An D, Gonzalez A, Hansen T, Latosinska A, et al.
Heart
. 2024 May;
110(19):1180-1187.
PMID: 38729636
Objective: Heart failure (HF) is characterised by collagen deposition. Urinary proteomic profiling (UPP) followed by peptide sequencing identifies parental proteins, for over 70% derived from collagens. This study aimed to...
7.
Gulizia M, Turazza F, Ameri P, Alings M, Collins R, De Luca L, et al.
G Ital Cardiol (Rome)
. 2024 Apr;
25(5):340-345.
PMID: 38639124
Background: Cancer is an important condition associated with the development of atrial fibrillation (AF). The objectives of the BLITZ-AF Cancer study were to collect real-life information on the clinical profile...
8.
Raat W, Housiaux E, Smeets M, Janssens S, Schoenmakers B, Vaes B
J Med Educ Curric Dev
. 2024 Mar;
11:23821205241232497.
PMID: 38464745
Physician-oriented online education could be a pathway to improve care for patients with heart failure, however, it is difficult to measure the impact of such education. Self-efficacy is a potential...
9.
Yu Y, Huang Q, An D, Raad J, Martens D, Latosinska A, et al.
Heliyon
. 2024 Feb;
10(2):e24867.
PMID: 38312576
Background: Immunosuppressive treatment in heart transplant (HTx) recipient causes osteoporosis. The urinary proteomic profile (UPP) includes peptide fragments derived from the bone extracellular matrix. Study aims were to develop and...
10.
Vandenbriele C, MPembele R, Dannenberg L, Metzen D, Zako S, Helten C, et al.
Int J Cardiol
. 2023 Dec;
399:131690.
PMID: 38160912
Background: Impella™ is increasingly used in cardiogenic shock. However, thromboembolic and bleeding events are frequent during percutaneous mechanical circulatory support (pMCS). Objective: Therefore, we aimed to explore the optimal anticoagulation...